home All News open_in_new Full Article
European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval
today 7 d. ago attach_file Economics
attach_file
Economics
attach_file
Other
attach_file
Culture
attach_file
Politics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Events
attach_file
Economics
attach_file
Other
attach_file
Economics
ID: 715513255